MedPath
NMPA Approval

乳酸依沙吖啶

国药准字H22023869

February 11, 2020

Drug Information

乳酸依沙吖啶

原料药

化学药品

February 11, 2020

Company Information

Applicant Company

Manufacturing Company

吉林辽源经济开发区友谊工业园区财富北路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

乳酸依沙吖啶 - NMPA 批准文号 | MedPath